TY - JOUR
T1 - Updates in the pharmacologic treatment of childhood depression
AU - Emslie, Graham J.
AU - Mayes, Taryn L.
AU - Hughes, Carroll W.
PY - 2000
Y1 - 2000
N2 - Significant advances are being made in the treatment of depression in children and adolescents. In a relatively short period, we have moved away from whether or not children get depressed to how to develop a comprehensive treatment strategy for depression in children and adolescents. It is expected that the increase in the understanding of the psychopharmacologic management of depression in children and adolescents will be greatly enhanced by the collaborative arrangements between universities, the National Institute of Mental Health, the Food and Drug Administration, and the pharmaceutical industry. Recent changes in federal regulations have greatly enhanced the amount of research being conducted in the pediatric age group. Although research into psychopharmacologic treatment of acute depression has increased, there remain many areas in need of further research, including continuation and maintenance treatment and treatment-resistant depression. The integration of psychotherapy and psychopharmacology and the increase in effectiveness trials, which assess outcomes in addition to symptom change (such as social and family functioning and economic changes) are needed.
AB - Significant advances are being made in the treatment of depression in children and adolescents. In a relatively short period, we have moved away from whether or not children get depressed to how to develop a comprehensive treatment strategy for depression in children and adolescents. It is expected that the increase in the understanding of the psychopharmacologic management of depression in children and adolescents will be greatly enhanced by the collaborative arrangements between universities, the National Institute of Mental Health, the Food and Drug Administration, and the pharmaceutical industry. Recent changes in federal regulations have greatly enhanced the amount of research being conducted in the pediatric age group. Although research into psychopharmacologic treatment of acute depression has increased, there remain many areas in need of further research, including continuation and maintenance treatment and treatment-resistant depression. The integration of psychotherapy and psychopharmacology and the increase in effectiveness trials, which assess outcomes in addition to symptom change (such as social and family functioning and economic changes) are needed.
UR - http://www.scopus.com/inward/record.url?scp=0034526287&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034526287&partnerID=8YFLogxK
U2 - 10.1016/S0193-953X(05)70199-4
DO - 10.1016/S0193-953X(05)70199-4
M3 - Article
AN - SCOPUS:0034526287
SN - 0193-953X
VL - 23
SP - 813
EP - 835
JO - Psychiatric Clinics of North America
JF - Psychiatric Clinics of North America
IS - 4
ER -